Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
Abstract Introduction This study estimated the minimal clinically important difference (MCID) for Mini Mental State Examination, Clinical Dementia Rating Scale sum of boxes, and Functional Activities Questionnaire across the Alzheimer's disease (AD) spectrum. Methods Retrospective analysis of t...
Saved in:
| Main Authors: | J. Scott Andrews, Urvi Desai, Noam Y. Kirson, Miriam L. Zichlin, Daniel E. Ball, Brandy R. Matthews |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.trci.2019.06.005 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perspective: Minimal clinically important difference (MCID) and Alzheimer's disease clinical trials
by: Jeffrey Cummings
Published: (2025-01-01) -
Three approaches to determining clinically meaningful benefit on the Cohen‐Mansfield Agitation Inventory in dementia clinical trials for agitation
by: Kathy Y. Liu, et al.
Published: (2025-04-01) -
The minimal clinically important difference changes greatly based on the patient's baseline clinical status
by: Marco Franceschini, et al.
Published: (2025-01-01) -
Neuropsychological and clinical variables associated with cognitive trajectories in patients with Alzheimer's disease
by: Marianna Riello, et al.
Published: (2025-05-01) -
Assessing clinical meaningfulness in clinical trials for Alzheimer's disease: A U.S. regulatory perspective
by: Teresa Buracchio, et al.
Published: (2025-04-01)